Total Debt
$75.3M
Net Debt
-$25.8M
Sana Biotechnology, Inc. currently has $75.3M in total debt. Net debt is -$25.8M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
SANA • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.08 | 0.10 | -0.03Net Cash | 0.37 | 20.2% |
| 2025-12-31 | 0.08 | 0.14 | -0.06Net Cash | 0.42 | 18.9% |
| 2025-09-30 | 0.09 | 0.15 | -0.06Net Cash | 0.44 | 20.6% |
| 2025-06-30 | 0.09 | 0.07 | 0.01 | 0.36 | 23.6% |
| 2025-03-31 | 0.09 | 0.10 | -0.01Net Cash | 0.45 | 20.5% |
| 2024-12-31 | 0.09 | 0.15 | -0.06Net Cash | 0.50 | 18.8% |
| 2024-09-30 | 0.10 | 0.20 | -0.10Net Cash | 0.56 | 17.2% |
| 2024-06-30 | 0.10 | 0.25 | -0.15Net Cash | 0.62 | 15.9% |
| 2024-03-31 | 0.11 | 0.31 | -0.20Net Cash | 0.68 | 15.6% |
| 2023-12-31 | 0.10 | 0.21 | -0.10Net Cash | 0.57 | 18.4% |
| 2023-09-30 | 0.10 | 0.27 | -0.17Net Cash | 0.63 | 15.3% |
| 2023-06-30 | 0.11 | 0.33 | -0.21Net Cash | 0.71 | 16.0% |
| 2023-03-31 | 0.11 | 0.35 | -0.23Net Cash | 0.75 | 15.3% |
| 2022-12-31 | 0.11 | 0.42 | -0.32Net Cash | 0.82 | 13.2% |
| 2022-09-30 | 0.11 | 0.49 | -0.37Net Cash | 0.90 | 12.4% |
| 2022-06-30 | 0.11 | 0.48 | -0.37Net Cash | 0.97 | 11.7% |
| 2022-03-31 | 0.11 | 0.51 | -0.40Net Cash | 1.05 | 10.7% |
| 2021-12-31 | 0.11 | 0.55 | -0.44Net Cash | 1.13 | 9.8% |
| 2021-09-30 | 0.10 | 0.60 | -0.50Net Cash | 1.23 | 8.0% |
| 2021-06-30 | 0.07 | 0.85 | -0.78Net Cash | 1.26 | 5.7% |
| 2021-03-31 | 0.07 | 0.96 | -0.89Net Cash | 1.30 | 5.4% |
| 2020-12-31 | 0.07 | 0.38 | -0.31Net Cash | 0.73 | 9.8% |
| 2020-09-30 | 0.07 | 0.45 | -0.38Net Cash | 0.77 | 9.2% |
| 2020-03-31 | 0.00 | 0.14 | -0.14Net Cash | 0.00 | — |
| 2019-12-31 | 0.05 | 0.14 | -0.09Net Cash | 0.42 | 11.5% |